Security key
03879J100
Arbutus Biopharma Corp - Common Shares, without par value (ABUS)
CUSIP: 03879J100
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Shares, without par value
- Shares outstanding
- 197,420,670
- Total 13F shares
- 118,112,086
- Share change
- +6,461,604
- Total reported value
- $364,964,865
- Put/Call ratio
- 48%
- Price per share
- $3.09
- Number of holders
- 162
- Value change
- +$19,645,984
- Number of buys
- 79
- Number of sells
- 61
Report period
Q2 2025
Institutions
162
Top holders
10
ABUS full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Arbutus Biopharma Corp SEC filings
Arbutus Biopharma Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03879J100
Recent filing periods:
Top shareholders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd. |
13D/G
3/4/5
|
10%+ Owner |
20%
|
38,847,462
|
$127,808,150 | $0 | 21 Feb 2025 | |
| MORGAN STANLEY |
13F
|
Company |
12%
|
23,792,389
|
$83,035,438 | — | 31 Mar 2025 | |
| Whitefort Capital Management, LP |
13F
|
Company |
6.7%
|
13,307,967
|
$46,444,805 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
6.5%
|
12,766,622
|
$44,555,511 | — | 31 Mar 2025 | |
| Two Seas Capital LP |
13F
|
Company |
4.8%
|
9,465,956
|
$33,036,186 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.5%
|
8,953,823
|
$31,248,842 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
4,363,507
|
$15,228,639 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
3,541,145
|
$12,362,189 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
1.3%
|
2,655,738
|
$9,268,526 | — | 31 Mar 2025 | |
| FOURSIXTHREE CAPITAL LP |
13F
|
Company |
1.2%
|
2,450,421
|
$8,551,969 | — | 31 Mar 2025 | |
| BlackBarn Capital Partners LP |
13F
|
Company |
1.2%
|
2,341,871
|
$8,173,130 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
2,075,948
|
$7,245,058 | — | 31 Mar 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.95%
|
1,879,114
|
$6,558,108 | — | 31 Mar 2025 | |
| Rubric Capital Management LP |
13F
|
Company |
0.85%
|
1,681,090
|
$5,867,004 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.8%
|
1,575,941
|
$5,500,034 | — | 31 Mar 2025 | |
| Rangeley Capital, LLC |
13F
|
Company |
0.68%
|
1,349,000
|
$4,708,010 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.68%
|
1,344,906
|
$4,693,722 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.65%
|
1,283,601
|
$4,479,767 | — | 31 Mar 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.63%
|
1,245,900
|
$4,348,191 | — | 31 Mar 2025 | |
| FourWorld Capital Management LLC |
13F
|
Company |
0.62%
|
1,226,710
|
$4,281,218 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.62%
|
1,222,065
|
$4,265,007 | — | 31 Mar 2025 | |
| Saba Capital Management, L.P. |
13F
|
Company |
0.5%
|
979,516
|
$3,418,511 | — | 31 Mar 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.29%
|
581,080
|
$2,027,969 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.27%
|
538,629
|
$1,879,816 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.26%
|
510,509
|
$1,781,676 | — | 31 Mar 2025 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.24%
|
467,882
|
$1,632,908 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.24%
|
467,383
|
$1,631,167 | — | 31 Mar 2025 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
0.24%
|
464,513
|
$1,621,150 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.23%
|
458,226
|
$1,599,209 | — | 31 Mar 2025 | |
| Freestone Capital Holdings, LLC |
13F
|
Company |
0.22%
|
442,500
|
$1,544,325 | — | 31 Mar 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.21%
|
419,337
|
$1,463,486 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.2%
|
402,361
|
$1,404,240 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.18%
|
348,797
|
$1,217,302 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.18%
|
348,220
|
$1,215,288 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.16%
|
313,307
|
$1,093,442 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.15%
|
295,341
|
$1,030,740 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.14%
|
280,760
|
$979,853 | — | 31 Mar 2025 | |
| Ledgewood Wealth Advisors, LLC |
13F
|
Company |
0.14%
|
278,436
|
$971,742 | — | 31 Mar 2025 | |
| Swiss National Bank |
13F
|
Company |
0.14%
|
276,300
|
$964,287 | — | 31 Mar 2025 | |
| Eisler Capital Management Ltd. |
13F
|
Company |
0.14%
|
275,000
|
$968,000 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.13%
|
261,836
|
$913,808 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.11%
|
226,165
|
$789,315 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.1%
|
200,757
|
$700,630 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.1%
|
192,292
|
$671,099 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.09%
|
183,248
|
$639,536 | — | 31 Mar 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
162,277
|
$566,347 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.08%
|
151,414
|
$528,435 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.07%
|
146,863
|
$512,552 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.07%
|
139,462
|
$486,722 | — | 31 Mar 2025 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.07%
|
132,758
|
$463,325 | — | 31 Mar 2025 |
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q2 2025
As of 30 Jun 2025,
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by
162 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
118,112,086 shares.
The largest 10 holders included
MORGAN STANLEY, Whitefort Capital Management, LP, BlackRock, Inc., Two Seas Capital LP, VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, ADAR1 Capital Management, LLC, and BlackBarn Capital Partners LP.
This page lists
162
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
167
Q2 2025 holders
162
Holder diff
-5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.